Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Adenosine A2a Receptor Antibodies:
anti-Mouse (Murine) Adenosine A2a Receptor Antibodies:
anti-Rat (Rattus) Adenosine A2a Receptor Antibodies:
Go to our pre-filtered search.
Human Polyclonal Adenosine A2a Receptor Primary Antibody for EIA, IF - ABIN950277
Buira, Dentesano, Albasanz, Moreno, Martín, Ferrer, Barrachina: DNA methylation and Yin Yang-1 repress adenosine A2A receptor levels in human brain. in Journal of neurochemistry 2010
Show all 4 references for ABIN950277
Rhesus Monkey Polyclonal Adenosine A2a Receptor Primary Antibody for ELISA, WB - ABIN185549
Rétey, Adam, Honegger, Khatami, Luhmann, Jung, Berger, Landolt: A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. in Proceedings of the National Academy of Sciences of the United States of America 2005
Show all 2 references for ABIN185549
Human Polyclonal Adenosine A2a Receptor Primary Antibody for EIA, WB - ABIN783921
van der Putten, Zuiderwijk-Sick, van Straalen, de Geus, Boven, Kondova, IJzerman, Bajramovic: Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia. in Journal of immunology (Baltimore, Md. : 1950) 2009
Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death.
Adenosine A2A receptor contributes to ischemic brain damage in newborn piglet.
Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model.
mRNA for adenosine A(1), A(2A), A(2B (show ADRA2B Antibodies)), and A(3) receptors was expressed in arterioles and venules. Protein for A(1), A(2A), and A(2B (show ADRA2B Antibodies)), but not A(3), was detected in both microvessel types and was further demonstrated on vascular endothelial cells
Study reveals presence of adenosine A(2A) and A(2B (show ADRA2B Antibodies)) receptors as well as a role for them in lacrimal gland secretion, and especially in synergy with purinergic and cholinergic stimulation.
This review will provide insight into the phenotypic changes that underline the resistance to death of liver cells preconditioned by pharmacological activation of A2aR and their implications to develop innovative strategies against liver IR damage
Data suggest that A2aR binding of antagonist (here, ZM241385) exhibits multistep drug-dissociation process, with antagonist consecutively interacting with topographically distinct regions/binding sites of A2aR.
activation of the A2AR reduced oxidative stress-induced (show SQSTM1 Antibodies) DNA damage and caspase 3 (show CASP3 Antibodies) activation in GABAergic neurons
(19)F nuclear magnetic resonance is used to quantify the conformational landscape occupied by the adenosine A2A receptor (A2AR), a prototypical class A G-protein-coupled receptor (show ADRA1A Antibodies)
ST1535 metabolites ST3932 and ST4206 are effective adenosine A2A receptor antagonists which maybe useful in treating Parkinson disease.
activation of A2A adenosine receptor (AR) with an FDA-approved agonist potently permeabilizes an in vitro primary human blood-brain barrier (hBBB (show HBB Antibodies)) to the passage of chemotherapeutic drugs and T cells.
Results show that ADORA1 (show ADORA1 Antibodies) rs2228079 and ADORA2A rs5751876 polymorphisms are associated with the risk of Gilles de la Tourette Syndrome, co-morbid disorders, and may affect the age of tics onset in Polish population.
ADORA2A and GRK5 (show GRK5 Antibodies) gene variants may influence the etiology of malaria infection.
Expression of NPP1 (show ENPP1 Antibodies) and 5'-nucleotidase (show NT5E Antibodies) by valve interstitial cells promotes the mineralization of the aortic valve through A2aR and a cAMP/PKA/CREB (show CREB1 Antibodies) pathway.
An association was observed for SNPs in ADORA2A and levodopa-induced dyskinesia in Parkinson's disease patients.
Plasminogen (show PLG Antibodies) activation contributes to wound repair and suggest that adenosine A2A receptor activation promotes wound closure by a mechanism that depends on tPA (show PLAT Antibodies).
These results show that the dysfunction of astrocytic A2AR, by controlling GLT (show SLC1A2 Antibodies)-I activity, triggers an astrocyte-to-neuron wave of communication resulting in disrupted glutamate (show GRIN1 Antibodies) homeostasis.
This study showed that the recruitment of intracellular A2AR signaling in the hippocampus is sufficient to trigger memory dysfunction.
A novel mutual suppression feedback loop between A2AR signaling and miR (show MLXIP Antibodies)-214 in inflammation.
Study shows the ability of A2AR inactivation or pharmacological blockade to control working memory deficits in the prodrome and early phases of R6/2 mice modeling Huntington's disease
adenosine-induced increase in coronary flow is partially mediated by Nox2 (show CYBB Antibodies)-derived H2O2, which critically depends upon the presence of A2A adenosine receptors
Expression of NPP1 (show ENPP1 Antibodies) and 5'-nucleotidase (show ACPP Antibodies) by valve interstitial cells promotes the mineralization of the aortic valve through A2aR and a cAMP/PKA/CREB (show CREB1 Antibodies) pathway.
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 (show PDCD1 Antibodies) through Enhanced Antitumor T-cell Responses
These data suggest that the use of pharmacologic A2AR antagonists may hold therapeutic potential in diminishing the rate of cancer development.
Adenosine A2A receptor immunoreactivity is localized at the highest levels of the striatum and external globus pallidus.
Activation of adenosine A(2A) receptors inhibited ROS (show ROS1 Antibodies) production by LPS (show IRF6 Antibodies)-stimulated equine neutrophils in a cAMP-dependent manner.
This gene encodes a protein which is one of several receptor subtypes for adenosine. The activity of the encoded protein, a G-protein coupled receptor family member, is mediated by G proteins which activate adenylyl cyclase. The encoded protein is abundant in basal ganglia, vasculature and platelets and it is a major target of caffeine.
adenosine A2a receptor
, adenosine receptor A2a
, adenosine receptor A2a.1
, A2a adenosine receptor
, adenosine receptor A2a-like
, adenosine receptor subtype A2a
, A2a, Rs
, Adenosine A2a-receptor